Antimalarial agent 49
Antimalarial agent 49 is an orally active antimalarial compound. Antimalarial agent 49 inhibits growth of Pf3D7 and PfK1 strains (IC50: 0.84 μM and 0.4 μM respectively) . Antimalarial agent 49 has antimalarial activity and inhibits the development of P. berghei liver stages. Antimalarial agent 49 can be used in the study of Plasmodium infection[1].
Product Specifications
UNSPSC
12352005
Target
Parasite
Related Pathways
Anti-infection
Field of Research
Infection
Smiles
O=C(C1=CC2=C(C(C3=CC=C(F)C=C3)=N1)NC4=C2C=CC=C4)NCC5=CN(C6=CC=CC(C(F)(F)F)=C6)N=N5
Molecular Formula
C28H18F4N6O
Molecular Weight
530.48
References & Citations
[1]Kushawaha AK, et al. Design, synthesis and evaluation of novel carboline-triazole hybrids as promising antimalarial agents. Eur J Med Chem. 2025 Jun 5;290:117514.
Shipping Conditions
Room temperature
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-173312/
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![FAM3A Mouse Monoclonal Antibody [7-B9]](https://cdn.genprice.uk/products/992/68dd1c8b061270361ea818d3/imageurl/m1008-10.webp)
